XETRA · Healthcare
Invest in Fresenius SE & Co. KGaA stock from India
Indian and foreign residents can buy Fresenius SE & Co. KGaA (FRE) shares directly through Paasa.
By Paasa · Updated
Fresenius SE & Co. KGaA at a glance
- Price
- €41.59-€1.70 (3.92%)
- Market cap
- €23.42B
- Day range
- €41.43 – €42.90
- P/E
- 15.12
- Dividend yield
- 2.52%
- Volume
- 1.48M
- 1 month
- -6.94%
- 6 months
- -7.06%
- YTD
- -15.09%
- 1 year
- -12.46%
- 5 years
- +2.46%
Fresenius SE & Co. KGaA statements, FY2021–FY2025
| Fiscal year | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Revenue | €22.9B | €21.8B | €21.1B | €21.3B | €37.1B |
| Gross profit | €5.7B | €5.4B | €5.0B | €5.2B | €9.8B |
| Operating income | €2.2B | €1.8B | €1.3B | €1.5B | €3.6B |
| Net income | €1.3B | €471.0M | −€594.0M | €1.4B | €1.8B |
| Earnings per share | €2.24 | €0.84 | −€1.05 | €2.44 | €3.26 |
| EBITDA | €3.7B | €3.1B | €2.7B | €3.1B | €7.0B |
| Total assets | €41.4B | €43.5B | €45.3B | €76.4B | €72.0B |
| Total debt | €11.9B | €13.6B | €15.8B | €27.8B | €27.2B |
| Cash and short-term investments | €1.6B | €2.0B | €2.6B | €2.3B | €2.7B |
| Shareholders' equity | €19.1B | €19.5B | €19.0B | €20.4B | €19.0B |
| Operating cash flow | €2.7B | €2.4B | €4.5B | €4.2B | €5.1B |
| Free cash flow | €1.2B | €1.5B | €3.3B | €2.3B | €3.0B |
| Capital expenditure | −€1.5B | −€923.0M | −€1.1B | −€1.9B | −€2.0B |
Fiscal years as reported, the latest ending 31 Dec 2025. Figures in EUR; a dash means the provider reported nothing for that line.
Peer comparison
| Company | Ticker | Price | Market cap |
|---|---|---|---|
| HCA Healthcare | HCA | $445.01 | $96.35B |
| Dr. Sulaiman Al Habib Medical Services | 4013.SR | $228.70 | $80.05B |
| IHH Healthcare | 5225.KL | $7.88 | $69.63B |
| Tenet Healthcare | THC | $260.57 | $20.98B |
| DaVita | DVA | $177.02 | $11.36B |
| Universal Health Services | UHS | $175.72 | $10.64B |
| Fresenius Medical Care AG & Co. KGaA | FME.DE | €36.72 | €9.77B |
Peers as grouped by the data provider. This is not an investment recommendation.
Analyst price targets
- Low
- —
- High
- —
- Median
- —
- Consensus
- —
Ratings: 1 buy · 0 hold · 0 sell. Consensus: Buy.
Published sell-side 12-month targets in EUR, aggregated by the data provider. They are not Paasa's view and not a forecast.
How to invest in Fresenius SE & Co. KGaA from India
Step 1
Open your Paasa account
KYC takes a few minutes: PAN, Aadhaar and address proof. Your brokerage account is opened in your own name with Interactive Brokers.
Step 2
Add funds from your Indian bank account
Remit up to $250,000 a year under the RBI's Liberalised Remittance Scheme. Your bank converts the rupees to US dollars at its rate on the day you remit, and Interactive Brokers converts the dollars to EUR when you buy.
Step 3
Search FRE and buy
Find Fresenius SE & Co. KGaA by name or by its ticker, FRE, and place your order.
Why invest in Fresenius SE & Co. KGaA from India
What Fresenius SE & Co. KGaA does
Fresenius SE & Co. KGaA operates as a diverse healthcare enterprise, supplying a comprehensive array of products and services primarily focused on dialysis, hospital management, and outpatient medical care. Its activities are structured across four main divisions: Fresenius Medical Care, Fresenius Kabi, Fresenius Helios, and Fresenius Vamed. Fresenius SE & Co. KGaA operates in the Medical - Care Facilities industry within the Healthcare sector.
Paasa handles the paperwork
Investing abroad brings paperwork with it: remittance filings, capital gains reporting, foreign asset disclosure. Paasa prepares all of it for you. Your India-ready tax reports arrive at year end, ready to file.
Frequently asked questions
Can I buy Fresenius SE & Co. KGaA stock from India?
Yes. Indian residents and NRIs can buy Fresenius SE & Co. KGaA (FRE) shares directly through Paasa. Fresenius SE & Co. KGaA is listed on XETRA, in the Medical - Care Facilities industry. Your money leaves India under the RBI's Liberalised Remittance Scheme and the shares are held in your own name at Interactive Brokers.
What tax do I pay in India when I sell Fresenius SE & Co. KGaA shares?
In India, gains on shares held for more than 24 months are long-term and taxed at 12.5%, and gains on shares held for 24 months or less are short-term and taxed at your income-tax slab rate. Both are worked out in rupees at the EUR/INR rate on the day you bought and the day you sold, so the currency move is part of the gain. Paasa's capital-gains statement gives you the figures for your return.